ChargePoint Technology expands into Europe with new Munich site
![](/46/pdcnewsitem/11/79/12/ChargePoint%20Munich.jpg)
The company has seen demand skyrocket in the region.
ChargePoint Technology, a pharmaceutical containment and aseptic processing specialist, has opened a new facility outside Munich, Germany in response to increasing demand.
The new 75m sq site will support customers in the region with onsite consultations, virtual demonstrations and technical support. The company, whose headquarters are in the UK, says the move aligns with its goal of expanding into the DACH region, which comprises of Germany, Austria and Switzerland.
ChargePoint Technology creates containment and aseptic transfer valves and single-use solutions that are essential for the safe transfer of powders during pharmaceutical and biopharmaceutical manufacturing. The Munich facility will be headed up by Patrick Werner, regional manager for the DACH region.
Speaking about the expansion, ChargePoint Technology CEO Chris Eccles said: ‘In the last four years we have tripled our order intake in the region and I’m sure this growth will continue with Patrick and the team now permanently based in the area. This new investment and expansion of the team in the DACH region demonstrates ChargePoint's commitment to the region and our valued customers. We will continue to add the resources necessary to support our customer base in the territory as we grow.’
The company reported significant growth in its business over the last year, which promted an expansion of its US offices. In January, ChargePoint also acquired US-based Terracon Corporation, a manufacturer of single-use products and accessories for mixing, transferring, and storing liquids and fluids in the biopharma and life science markets.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News On Track at Pharmapack 2024 - The Track Sponsor interview: BD Pharmaceuticals
January 2024 brings both a new year and Europe’s leading packaging and drug delivery event. Bringing the world’s experts in pharmaceutical packaging together in Paris, France, Pharmapack 2024 brings exciting opportunities to learn and colla... -
News CPHI Pharma Awards 2023 – API Development and Innovation Winners: Snapdragon Chemistry, a Cambrex Company
After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October. In this series of interviews, we speak to the teams behind the award-winning projects, concepts, and technologies. -
News PharmaKure gains authorisation for next stage testing on Alzheimer's treatment
Clinical stage pharmaceutical company PharmaKure gains permission from UK authorities to enter into further testing for PK051 for the treatment of patients with mild cognitive impairment associated with Alzheimer's disease. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News Navigating the Future: Challenges and Opportunities in Pharma Innovation and Investment – CPHI Barcelona 2023 Roundtable Report
In this comprehensive downloadable report, hear from a range of experts in finance and investment in the pharma industry on what investment trends will be shaping the future of the industry, in Catalonia, and the wider world. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance